Arya Roy/X
Jun 4, 2025, 04:08
Arya Roy: SERENA-6 – Establishing a new pathway for utilizing ctDNA for resistant mutations and early treatment changes
Arya Roy, Hematology-Oncology Fellow at Roswell Park Comprehensive Cancer Center, shared a post on X:
“SERENA-6: Establishing a new pathway for utilizing ctDNA for resistant mutations and early treatment changes!
Improvement in PFS: 16 vs 9.2 months, QoL, acceptable toxicity. Qn: Will this improve OS.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 3, 2025, 10:55
Jul 3, 2025, 10:25
Jul 3, 2025, 10:24
Jul 3, 2025, 10:16
Jul 3, 2025, 10:15
Jul 3, 2025, 10:04